134 related articles for article (PubMed ID: 32008406)
1.
Ntziachristos P
Leuk Lymphoma; 2020 Mar; 61(3):501-503. PubMed ID: 32008406
[No Abstract] [Full Text] [Related]
2. Promyelocyte-like blasts in B-lymphoblastic leukemia of a 67-year-old male patient.
Ma Y; Leng Q; Zhao Y; Wang E
Int J Hematol; 2019 Dec; 110(6):645-646. PubMed ID: 31555970
[No Abstract] [Full Text] [Related]
3. High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.
Tasian SK; Hurtz C; Wertheim GB; Bailey NG; Lim MS; Harvey RC; Chen IM; Willman CL; Astles R; Zebrowski A; Reshmi SC; Li MM; Frey NV; Luger SM; Carroll M; Perl AE
Leukemia; 2017 Apr; 31(4):981-984. PubMed ID: 27932787
[No Abstract] [Full Text] [Related]
4. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
5. Your dilemma, my identity: unusual immunogenetic profiles of pediatric B cell acute lymphoblastic leukemia.
Gupta A; Goyal M; Nidamanuri KR; Dattatreya PS
Indian J Pathol Microbiol; 2014; 57(1):78-80. PubMed ID: 24739837
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous involvement as the form of presentation in B-cell lymphoblastic leukemia/lymphoma].
López Almaraz R; Raya Sánchez JM; Domínguez Suárez M; Brito Barroso Mf Mf; Rodríguez Luis J
An Esp Pediatr; 2002 Dec; 57(6):578-81. PubMed ID: 12466084
[TBL] [Abstract][Full Text] [Related]
7. B-lymphoblastic leukemia arising in a patient with chronic neutrophilic leukemia.
Boddy CS; Tan BT; Aoki J
Blood Adv; 2020 Nov; 4(21):5389-5392. PubMed ID: 33147336
[TBL] [Abstract][Full Text] [Related]
8. Prognostic irrelevance of CD34 expression in childhood B-precursor acute lymphoblastic leukemia.
Indolfi P; Casale F; Farzati B; D'Angelo V; De Sangro C; Rinaldi B
Haematologica; 1999 Jun; 84(6):567-8. PubMed ID: 10366809
[No Abstract] [Full Text] [Related]
9. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
Yaguchi A; Ishibashi T; Terada K; Ueno-Yokohata H; Saito Y; Fujimura J; Shimizu T; Ohki K; Manabe A; Kiyokawa N
Int J Hematol; 2017 Aug; 106(2):269-281. PubMed ID: 28378055
[TBL] [Abstract][Full Text] [Related]
10. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
13. Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia.
Blin N; Méchinaud F; Talmant P; Garand R; Boutard P; Dastugue N; McIntyre EA; Harousseau JL; Avet-Loiseau H
Leukemia; 2008 May; 22(5):1056-9. PubMed ID: 18007578
[No Abstract] [Full Text] [Related]
14. HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation.
Jin X; Cao Y; Wang L; Sun R; Cheng L; He X; Xiao X; Jiang Y; Li Q; Zhang H; Lu W; Lyu C; Jiang Y; Meng J; Zhao M
Leukemia; 2020 Mar; 34(3):909-913. PubMed ID: 31628429
[No Abstract] [Full Text] [Related]
15. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia].
Quijano SM; Torres MM; Vásquez LE; Cuéllar GE; Romero ML; Martín EL; Linares A; Castaño S; Sarmiento IC; Cabrera E; Uribe GI; Andrade RE; Saavedra CE
Biomedica; 2013; 33(3):468-86. PubMed ID: 24652183
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Ikaros in B Cell Acute Lymphoblastic Leukemia].
Zhang HY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1194-8. PubMed ID: 26314472
[TBL] [Abstract][Full Text] [Related]
18. Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia.
Turazzi N; Fazio G; Rossi V; Rolink A; Cazzaniga G; Biondi A; Magnani CF; Biagi E
Br J Haematol; 2018 Sep; 182(6):939-943. PubMed ID: 28832950
[No Abstract] [Full Text] [Related]
19. Mutant PRPS1: a new therapeutic target in relapsed acute lymphoblastic leukemia.
Mullighan CG
Nat Med; 2015 Jun; 21(6):553-4. PubMed ID: 26046573
[No Abstract] [Full Text] [Related]
20. An immune window of opportunity to prevent childhood B cell leukemia.
Cobaleda C; Vicente-Dueñas C; Sánchez-García I
Trends Immunol; 2021 May; 42(5):371-374. PubMed ID: 33773925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
